Germline BRCA1/2 Mutations and Severe Haematological Toxicities in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
European Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Germline BRCA1/2 Mutations and Severe Haematological Toxicities in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy
Eur. J. Cancer 2021 Mar 01;145(xx)44-52, J Furlanetto, V Möbus, A Schneeweiss, K Rhiem, H Tesch, JU Blohmer, K Lübbe, M Untch, C Salat, J Huober, P Klare, R Schmutzler, FJ Couch, B Lederer, B Gerber, DM Zahm, I Bauerfeind, V Nekljudova, C Hanusch, C Jackisch, T Link, E Hahnen, S Loibl, PA FaschingFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.